Strados Labs has developed a Remote Electronic Stethoscope Platform (RESP), a clinically validated medical device system aimed toward providing remote monitoring for outpatient settings as well as delivering respiratory monitoring to inpatient clinical teams throughout the duration of care. The RESP technology is a product-as-a-service that includes the patient-friendly bioacoustic sensors, the platform and support services. Strados’ non-invasive device is cleared as an FDA 501(k) Class II device and captures lung sounds and chest wall motions that are wirelessly transmitted through a mobile app to a web application to be analyzed for changes in respiratory health.